AU2010202656A1 - Lens Composition - Google Patents
Lens Composition Download PDFInfo
- Publication number
- AU2010202656A1 AU2010202656A1 AU2010202656A AU2010202656A AU2010202656A1 AU 2010202656 A1 AU2010202656 A1 AU 2010202656A1 AU 2010202656 A AU2010202656 A AU 2010202656A AU 2010202656 A AU2010202656 A AU 2010202656A AU 2010202656 A1 AU2010202656 A1 AU 2010202656A1
- Authority
- AU
- Australia
- Prior art keywords
- lens
- composition
- present
- lens composition
- lithium bicarbonate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
- G02B1/04—Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
- G02B1/041—Lenses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0618—Psychological treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
- A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
- A61N2005/0645—Applicators worn by the patient
- A61N2005/0647—Applicators worn by the patient the applicator adapted to be worn on the head
- A61N2005/0648—Applicators worn by the patient the applicator adapted to be worn on the head the light being directed to the eyes
Description
-1 P/00/011 28/5/91 Regulation 3.2 AUSTRALIA Patents Act 1990 ORIGINAL COMPLETE SPECIFICATION STANDARD PATENT Name of Applicant: Clayton Earl Martin Actual Inventor Clayton Earl Martin Address for service is: WRAYS Ground Floor, 56 Ord Street West Perth WA 6005 Attorney code: WR Invention Title: Lens Composition The following statement is a full description of this invention, including the best method of performing it known to me:- -2 "Lens composition" Field of the Invention The present invention relates to a lens composition. More particularly, the lens composition of the present invention is intended to remove or at least 5 substantially decrease the transmission through the lens of potentially damaging components, including but not limited to infrared rays. Background Art Optical lenses are used in a variety of circumstances. Such circumstances include glasses and sun glasses intended to be worn by individuals to aid in the 10 correction of defects in their sight and/or in the protection of their eyes from glare and harmful UV rays that are commonly present. However, the effectiveness of presently known lenses varies greatly in this regard. Present optical lenses are generally without any role in therapeutic treatment and remedies of physical and mental conditions. 15 One object of the present invention is to provide a lens composition that provides an improvement in such compared with lens compositions of the prior art, or at least provides a useful alternative thereto. Throughout this specification, unless the context requires otherwise, the word "comprise", or variations such as "comprises" or "comprising", will be understood 20 to imply the inclusion of a stated integer or group of integers but not the exclusion of any other integer or group of integers. The preceding discussion of the background art is intended to facilitate an understanding of the present invention only. It should be appreciated that the discussion is not an acknowledgement or admission that any of the material 25 referred to was part of the common general knowledge in Australia as at the priority date of the application.
-3 It is to be understood that the term "lens" is to be interpreted broadly herein unless the context clearly requires otherwise. For example, "lens" may include a sheet or block of material without any magnifying effect, such as a window. 5 Disclosure of the Invention In accordance with the present invention there is provided a lens composition comprising lithium bicarbonate and vitamin C. Preferably, the lithium bicarbonate is present at a concentration of between about 2-20% by weight. 10 In accordance with the present invention there is further provided a method for the treatment of an individual suffering from one or more of schizophrenia, bipolar disorder and depression, the method comprising exposing the or each individual to light that has passed through an optical device in which is provided one or more lenses, the composition of the or each lens comprises lithium 15 bicarbonate and vitamin C. Preferably, the concentration of lithium bicarbonate is between about 2-20% by weight. In accordance with the present invention there is still further provided a method for the treatment of an individual suffering from conditions of the eye, the 20 method comprising exposing the or each individual to light that has passed through an optical device in which is provided one or more lenses, the composition of the or each lens comprises lithium bicarbonate and vitamin C. Preferably, the concentration of lithium bicarbonate is between about 2-20% by weight. 25 Best Mode(s) for Carrying Out the Invention In accordance with one embodiment of the present invention a lens composition -4 is provided, the lens composition comprising lithium bicarbonate in addition to the substantive components of a lens, for example various plastic materials and/or glass. Lithium bicarbonate is provided in the lens composition as a concentration of about 2-20% by weight. 5 The lens composition further comprises vitamin C which is also dissolved in the substantive lens material. It is understood by the Applicant that a lens composition in accordance with the present invention is able to function in the promotion of healing of the eye of an individual utilising the lens composition and may further ameliorate or cure diseases and conditions of the brain, such 10 conditions including schizophrenia, bipolar disorder and depression. It is envisaged that the incorporation of vitamin C in the lens composition of the present invention provides a flow of neutrinos to the individual exposed to light passed through the lens composition of the present invention. It is further envisaged that symptoms of the conditions noted previously and also biological 15 tissue damage may be healed, at least in part through exposure to light that is passed through a lens composition in accordance with the present invention. It is still further envisaged that the lens composition of the present invention may be utilised in any one or more of car windows, house windows, tanning beds, cameras, microscopes, lasers and additional optical instruments and articles of 20 such general nature. Without being limited by theory, the Applicant believes that the lithium bicarbonate component of the lens composition of the present invention contributes to a greater ease of vision when compared to lenses not formed of the lens composition of the present invention. It is envisaged that lithium 25 bicarbonate absorbs potentially damaging infrared rays present in light that is transmitted through the lens composition. In this way the cornea, lens and retina of the eye are protected, at least in part, from damage that might be caused by those infrared rays. It is further envisaged that the infrared rays absorbed by the lithium carbonate may be converted into rays that contribute to 30 a healing effect in the tissues that they fall on.
-5 In one form of the present invention the lens composition may be "fine tuned" so as to change wave length of the light passing through the lens composition to maximise the healing properties therefrom. For example, the percentage composition of lithium bicarbonate by weight present in the composition may be 5 adjusted by a manufacturer to achieve a desired effect. In a second form of the present invention there is provided a method for the treatment of one or more individuals suffering from conditions of the brain, including one or more of schizophrenia, bipolar disorder and depression. This method comprises exposing the or each individual to light that has passed 10 through an optical device in which is provided one or more lenses, the composition of the or each lens being in accordance with that described hereinabove. In a further form of the present invention there is provided a method for the treatment of an individual suffering from conditions of the eye. This method 15 comprising exposing the or each individual to light that has passed through an optical device in which is provided one or more lenses, the composition of the or each lens being in accordance with that described hereinabove. It is clear to the Applicant that all types of spectacles, or glasses, used for the correction of short or long-sightedness, and/or simply for use as sunglasses, are 20 appropriate apparatus in which lenses formed of the lens composition of the present invention may be provided. Modifications and variations such as would be apparent to the skilled addressee are considered to fall within the scope of the present invention.
Claims (6)
1. A lens composition comprising lithium bicarbonate and vitamin C.
2. A lens composition according to claim 1, wherein the lithium bicarbonate is present at a concentration of between about 2-20% by weight. 5
3. A method for the treatment of an individual suffering from one or more of schizophrenia, bipolar disorder and depression, the method comprising exposing the or each individual to light that has passed through an optical device in which is provided one or more lenses, the composition of the or each lens comprises lithium bicarbonate and vitamin C. 10
4. A method according to claim 3, wherein the concentration of lithium bicarbonate is between about 2-20% by weight.
5. A method for the treatment of an individual suffering from conditions of the eye, the method comprising exposing the or each individual to light that has passed through an optical device in which is provided one or more lenses, the 15 composition of the or each lens comprises lithium bicarbonate and vitamin C.
6. A method according to claim 5, wherein the concentration of lithium bicarbonate is between about 2-20% by weight.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2010202656A AU2010202656A1 (en) | 2009-08-14 | 2010-06-25 | Lens Composition |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2009903834A AU2009903834A0 (en) | 2009-08-14 | Lens Composition | |
| AU2009903834 | 2009-08-14 | ||
| AU2010202656A AU2010202656A1 (en) | 2009-08-14 | 2010-06-25 | Lens Composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2010202656A1 true AU2010202656A1 (en) | 2011-03-03 |
Family
ID=43629934
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2010202656A Abandoned AU2010202656A1 (en) | 2009-08-14 | 2010-06-25 | Lens Composition |
Country Status (1)
| Country | Link |
|---|---|
| AU (1) | AU2010202656A1 (en) |
-
2010
- 2010-06-25 AU AU2010202656A patent/AU2010202656A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6677382B2 (en) | Myopia Prevention Article | |
| WO2008057990A3 (en) | Optical devices with reduced chromatic aberration | |
| CN104020583B (en) | Optical lens capable of resisting blue light | |
| US20060238703A1 (en) | Therapeutic contact lens for pseudo-aphakic eyes and/or eyes with retinal neuro-degeneration | |
| AR067986A1 (en) | PROVISION FOR THE TREATMENT OF PRESBIOPIA | |
| BRPI0715431B8 (en) | low-tack otolaryngological and ophthalmic device materials | |
| FR2989179B3 (en) | LENSES, DEVICES, PROCESSES, AND SYSTEMS FOR REFRACTION ERROR | |
| JP6629343B2 (en) | Optical components | |
| JP2013523273A5 (en) | ||
| EA016737B1 (en) | Safety element for protection of healthy eyes and therapy and prophylaxis device (embodiments) | |
| EA200801699A1 (en) | THERAPEUTIC AND PROPHYLACTIC OPHTHALMIC LENSES FOR PATIENTS WITH PSEUDO-AFAHIC VISION AND / OR PATIENTS OF THE RETARDANTS | |
| US10117778B2 (en) | Goggle lens | |
| CN117529250A (en) | Low haze UV blocking removable lens stack | |
| CN203870340U (en) | Blue light protection optical lens | |
| IES86544B2 (en) | Diopter configured to restrict electromagnetic radiations damaging the visual system | |
| CN206282043U (en) | A kind of medical screening glass and its glasses | |
| US7832857B2 (en) | Microbial cellulose contact lens | |
| AU2010202656A1 (en) | Lens Composition | |
| CN203870282U (en) | High-light-resistant optical eyeglass specially used by driver | |
| CN205258313U (en) | Ultraviolet protection lens | |
| Davey et al. | Eye protection in psoralen photochemotherapy | |
| WO2010110698A2 (en) | Spectral sphero-prismatic glasses | |
| CA2873437C (en) | Uv-blocking silicone hydrogel composition and silicone hydrogel contact lens containing thereof | |
| RU128487U1 (en) | ARTIFICIAL EYE CRYSTAL (OPTIONS) | |
| Stavarache et al. | PHYSICO-CHEMICAL CHARACTERIZATION OF POLYMERIC FILMS USED IN OPHTHALMOLOGY. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |